Specialty industrial machinery · Industrials · Fiscal year ends Dec 31
ITT reported revenue of $3.9B in the fiscal year ended Dec 2025, up 8.5% from the year before. Operating income was $685M, an operating margin of 17.4%, and net income was $488M. Operating cash flow of $669M less capital expenditure of $121M left free cash flow of $548M. It held more cash than debt (net cash $1.2B).
Ranks among the 33 specialty industrial machinery companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2,765 | 2,988 | 3,283 | 3,631 | 3,939 |
| Cost of revenue | 1,866 | 2,065 | 2,173 | 2,381 | 2,546 |
| Gross profit | 900 | 922 | 1,110 | 1,249 | 1,392 |
| Research & development | 94.9 | 96.5 | 103 | 116 | 111 |
| Selling, general & admin | 382 | 374 | 468 | 503 | 597 |
| Operating income | 504 | 468 | 531 | 678 | 685 |
| Net interest incomeBanks | 1.1 | −6.4 | −10.4 | – | – |
| Interest expense | – | 10.9 | 19.2 | 36.6 | 48.1 |
| Pre-tax income | 509 | 462 | 522 | 650 | 652 |
| Income tax | 190 | 91.1 | 105 | 126 | 160 |
| Net income | 316 | 367 | 412 | 520 | 488 |
| Diluted EPS | 3.66 | 4.38 | 4.98 | 6.32 | 6.11 |
| Diluted shares | 86.5 | 83.7 | 82.7 | 82.3 | 79.9 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 648 | 561 | 489 | 439 | 1,743 |
| Receivables | 555 | 629 | 675 | 703 | 756 |
| Inventory | 431 | 534 | 575 | 612 | 672 |
| Current assets | 1,722 | 1,837 | 1,858 | 1,886 | 3,354 |
| Net PP&E | 509 | 527 | 561 | 577 | 627 |
| Goodwill | 924 | 965 | 1,016 | 1,430 | 1,511 |
| Total assets | 3,565 | 3,780 | 3,933 | 4,731 | 6,310 |
| Payables | 373 | 401 | 437 | 458 | 465 |
| Deferred revenue | 46.6 | 70.2 | 95.9 | 119 | 176 |
| Current liabilities | 928 | 1,186 | 1,038 | 1,333 | 1,298 |
| Short-term debt | 2.2 | 2.2 | 2.3 | 2.6 | 2.8 |
| Long-term debt | 9.9 | 7.7 | 5.7 | 233 | 522 |
| Total liabilities | 1,335 | 1,523 | 1,394 | 1,946 | 2,219 |
| Shareholders' equity | 2,226 | 2,248 | 2,528 | 2,779 | 4,084 |
| Backlog (remaining obligations) | 891 | 1,079 | 1,247 | 1,594 | 1,876 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | −8.4 | 278 | 538 | 563 | 669 |
| Capital expenditure | 88.4 | 104 | 108 | 124 | 121 |
| Free cash flow | −96.8 | 174 | 430 | 439 | 548 |
| Depreciation & amortisation | 113 | 107 | 109 | 137 | 143 |
| Stock-based compensation | 16.5 | 18.1 | 20.2 | 25.9 | 36.2 |
| Acquisitions | 0.0 | 147 | 79.3 | 865 | 6.8 |
| Share buybacks | 105 | 245 | 60.0 | 105 | 521 |
| Dividends paid | 75.8 | 87.9 | 95.8 | 105 | 111 |
| Dividend per share | 0.88 | 1.06 | 1.16 | 1.28 | 1.40 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 8.1% | 9.9% | 10.6% | 8.5% |
| Operating income growth (YoY) | – | −7.2% | 13.4% | 27.8% | 0.9% |
| EPS growth (YoY) | – | 19.7% | 13.7% | 26.9% | −3.3% |
| Gross margin | 32.5% | 30.9% | 33.8% | 34.4% | 35.4% |
| Operating margin | 18.2% | 15.7% | 16.2% | 18.7% | 17.4% |
| Net margin | 11.4% | 12.3% | 12.6% | 14.3% | 12.4% |
| Return on equityBlank when equity is negative | 14.2% | 16.3% | 16.3% | 18.7% | 11.9% |
| ROCEEBIT ÷ (assets − current liabilities) | 19.1% | 18.0% | 18.3% | 20.0% | 13.7% |
| Free cash flow margin | −3.5% | 5.8% | 13.1% | 12.1% | 13.9% |
| Cash conversion (CFO ÷ net income) | −0.03x | 0.76x | 1.31x | 1.08x | 1.37x |
| Receivable days | 73 | 77 | 75 | 71 | 70 |
| Inventory days | 84 | 94 | 97 | 94 | 96 |
| Payable days | 73 | 71 | 73 | 70 | 67 |
| Interest cover | – | 42.9x | 27.6x | 18.5x | 14.2x |
| Debt ÷ equity | 0.01x | 0.00x | 0.00x | 0.08x | 0.13x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | −635 | −551 | −481 | −204 | −1,219 |
| Current ratio | 1.86x | 1.55x | 1.79x | 1.41x | 2.58x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.